Latest Insights on ETHE
This New Strategy Makes Sense of Biotechs’ Erratic Moves March 30, 2022 Investment Opportunities, Stocks, Winning Investor Daily I find one type of stock equal parts frustrating and fascinating — biotechs.
With Puts, You’ll Never Sweat Another Market Drop March 30, 2022 Investing, Options Bootcamp, Trading Strategies, True Options Masters The market today reminds Amber of 2008 — but she's not worried. She knows she can profit on the downside with put options...
How We’re Stock Market Survivors — and Thrivers March 29, 2022 Investing, Real Talk, Stocks (5-minute video) Many investors get washed out. But the few who do it like us survive — and thrive…
Inverse Leveraged ETFs: Perfect Short or Buyer Beware? March 29, 2022 Big Picture. Big Profits., Investing, U.S. Economy That led to a discussion of ways to make money in a downturn. We covered hedging currencies, like the Swiss franc and Japanese yen. We spoke about gold. We considered commodities, agreeing they were a good short-term play, but would suffer if rising interest rates led to a recession. Eventually, we came to inverse leveraged exchange-traded funds (ETFs) … those tempting plays that promise to make money when markets decline…
Tesla’s Split-Second Decision, Beyond’s Plant-Based Problem & Please Yield March 28, 2022 Great Stuff It’s Splitsville For Tesla Great Ones, what makes the Musk Man guard his musk? Profits! What makes Tesla (Nasdaq: ) a wonder of Wall Street? Profits! What makes TSLA stock come up like thunder? Profits! What has Musk got that other electric vehicle (EV) makers ain’t got? Profits? Yeah, pretty much. Tesla CEO Elon Musk […]





